Premium Nahrungsergänzungsmittel | artgerecht

Piperacillin – Antibiotic: Action & Uses

Piperacillin is a broad-spectrum antibiotic from the acylaminopenicillin group, effective against a wide range of gram-positive and gram-negative bacteria.

Regular tips about health Regular tips about health

Things worth knowing about "Piperacillin"

Piperacillin is a broad-spectrum antibiotic from the acylaminopenicillin group, effective against a wide range of gram-positive and gram-negative bacteria.

What is Piperacillin?

Piperacillin is a semi-synthetic, broad-spectrum antibiotic belonging to the acylaminopenicillin subclass of penicillins. It is active against a wide variety of gram-positive and gram-negative bacteria and is primarily used in hospital settings for the treatment of serious infections. In clinical practice, piperacillin is most commonly administered in combination with the beta-lactamase inhibitor tazobactam (piperacillin/tazobactam) to enhance its effectiveness against resistant organisms.

Indications

Piperacillin is indicated for the treatment of serious bacterial infections caused by susceptible organisms. Common clinical indications include:

Severe respiratory tract infections such as pneumonia, particularly hospital-acquired (nosocomial) pneumonia
Urinary tract infections, including pyelonephritis
Intra-abdominal infections
Skin and soft tissue infections
Bone and joint infections
Sepsis (bloodstream infections)
Infections in immunocompromised patients, e.g., febrile neutropenia following chemotherapy

Mechanism of Action

Piperacillin belongs to the class of beta-lactam antibiotics. It works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). These proteins are enzymes responsible for building and cross-linking the peptidoglycan layer of the bacterial cell wall. When piperacillin binds to PBPs, the structural integrity of the cell wall is compromised, leading to bacterial cell death. Piperacillin is therefore classified as a bactericidal antibiotic.

Compared to earlier penicillins, piperacillin has an extended spectrum of activity that includes gram-negative rod-shaped bacteria such as Pseudomonas aeruginosa. However, because some bacteria produce beta-lactamase enzymes that break down and inactivate piperacillin, it is routinely combined with tazobactam in clinical use to overcome this resistance mechanism.

Administration and Dosage

Piperacillin is administered exclusively parenterally (intravenously or intramuscularly), as it is not adequately absorbed when taken orally. The exact dosage depends on the type and severity of the infection, the patient's renal function, and body weight. In adults, typical dosing of piperacillin/tazobactam ranges from 3.375 g to 4.5 g every 6 to 8 hours. Dose adjustments are required in patients with significant renal impairment.

Side Effects

As with all antibiotics, piperacillin can cause side effects. The most commonly reported include:

Hypersensitivity reactions (skin rash, urticaria, and rarely anaphylactic shock)
Gastrointestinal complaints such as nausea, vomiting, or diarrhea
Elevated liver enzymes (transaminases)
Blood count changes, including thrombocytopenia (low platelet count) or neutropenia
Local reactions at the injection site
Electrolyte imbalances, particularly hypokalemia (low potassium levels)

Piperacillin is contraindicated in patients with a known allergy to penicillins or other beta-lactam antibiotics.

Antibiotic Resistance

The growing problem of antibiotic resistance is a global public health concern. Some bacteria have developed mechanisms to render piperacillin ineffective, including the production of beta-lactamases (such as extended-spectrum beta-lactamases, or ESBLs) or alterations in penicillin-binding proteins. The combination with tazobactam can overcome some of these resistance mechanisms, but not all. Appropriate use of piperacillin is therefore critical to preserving its long-term effectiveness.

References

Brunton L.L., Hilal-Dandan R., Knollmann B.C. (Eds.) - Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 13th edition. McGraw-Hill Education, New York, 2018.
European Medicines Agency (EMA) - Summary of Product Characteristics: Piperacillin/Tazobactam. Available at: www.ema.europa.eu
World Health Organization (WHO) - WHO Model List of Essential Medicines, 23rd edition. Geneva: WHO, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.